Texas MG217 Eczema Cream Lawsuit

In May 2026, Pharmacal recalled MG217® Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream due to a risk of severe infections with the bacteria Staphylococcus aureus. The cream was sold nationwide, including at H-E-B grocery stores across Texas and on Amazon.

Need a Texas Staph Infection Lawyer? Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged. If you developed a staph infection after using MG217 Eczema Cream, contact our lawyers immediately. You may be entitled to compensation by filing a lawsuit.

Quick Facts About This Recall

Recalled by: Pharmacal (Jackson, WI)
Product: MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream, 6oz tube
Recall date: May 8, 2026 (FDA published May 12, 2026)
Lot affected: Lot 1024088, expiration November 2026
Product code: 5106 | UPC: 012277051067
Hazard: Contamination with Staphylococcus aureus, which can cause skin infections, bloodstream infections, endocarditis, and sepsis
Where sold: Nationwide — wholesale, retail (H-E-B grocery), and Amazon
What to do: Stop using and discard the product
Official source: FDA recall notice

Pharmacal Recalls MG217 Eczema Cream for Staphylococcus aureus Contamination

On May 8, 2026, Pharmacal of Jackson, Wisconsin, issued a nationwide consumer-level recall of one lot of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream. Pharmacal warned that it may be contaminated with Staphylococcus aureus. The company said no infections or adverse events related to this recall have been reported as of the announcement date.

What Is the Risk of Staphylococcus aureus?

Staphylococcus aureus, commonly called “staph,” is a bacteria that lives harmlessly on the skin of many healthy people but can cause serious infection when it enters the body through broken or compromised skin.

Because eczema cream is designed to be applied directly to inflamed, cracked, or broken skin, contamination of the product creates a direct route for the bacteria to enter the body.

In its FDA-published recall notice, Pharmacal described the risk as follows:

“Use of the product could result in a range of infections from localized to severe or life-threatening adverse events. Patients with weakened immune systems or compromised skin — such as those with wounds, burns, or skin disorders — are at increased risk for serious infections, including skin and skin structure infections, infective endocarditis (infection of the heart valves), bone and joint infections, bloodstream infections, and life-threatening conditions like sepsis and septic shock.”

Possible Staphylococcus aureus infections include:

Skin and soft tissue infections — boils, abscesses, cellulitis, impetigo
Bloodstream infections (bacteremia)
Sepsis and septic shock
Infective endocarditis (heart valve infection)
Pneumonia
Osteomyelitis (bone infection)
Septic arthritis (joint infection)
Toxic shock syndrome

Some strains, such as methicillin-resistant Staphylococcus aureus (MRSA), are resistant to common antibiotics and are linked to longer hospital stays, higher treatment costs, and increased mortality.

Who Is at Highest Risk?

Pharmacal identified two groups at greatest risk: people with weakened immune systems, and people with compromised skin such as wounds, burns, or skin disorders. Eczema patients fall directly into the second category, because the symptoms of eczema involve inflamed, cracked, and broken skin.

Which Products Are Affected?

MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream — 6oz tube
Lot number: 1024088 (printed on the crimped end of the tube)
Expiration date: November 2026
Product code: 5106
UPC: 012277051067

Where Were They Sold?

The recalled product was distributed nationwide through wholesale distributors, retail stores, and internet distributors. Confirmed retail and internet distributors include H-E-B grocery stores and Amazon. H-E-B operates more than 300 stores across Texas, including locations throughout Houston, San Antonio, Austin, and the Rio Grande Valley.

If you have the recalled product at home, Pharmacal recommends that you stop using and discard the product. For updates, visit the FDA recall page.

How Many People Were Affected?

As of the recall announcement, Pharmacal had not received any reports of adverse events related to the contamination. The recall is precautionary and applies to one lot distributed nationwide.

Because the product was widely available at H-E-B grocery stores and Amazon (both of which serve large numbers of Texas customers) the potential exposure is significant. If you used MG217 Eczema Cream from the recalled lot and developed a skin infection, bloodstream infection, or sepsis, our Texas lawyers may be able to help.

Legal Help for Staph Infection Victims in Texas

A staph infection that turns invasive can result in hospitalization, IV antibiotics, surgery to drain abscesses, and in serious cases, sepsis or death. Treatment for MRSA infections in particular can be lengthy and expensive, and outcomes are worse than for non-resistant strains.

Texans who developed a staph infection after using the recalled MG217 Eczema Cream may be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages. A Texas product liability lawyer can help you understand your legal options.

Need a Texas MG217 Eczema Cream Lawsuit?

Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.

Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”

The Clark Firm has assembled a team of trial lawyers with more than 100 years of experience, participation in over 600 jury trials, and $260 million in verdicts and/or settlements. Please use the form below to contact our law firm for a free case review.